GLOBUS MED INC

NYSE: GMED
$49.16
+$0.49 (+1.0%)
Closing price July 2, 2020
It's another day that the markets are open, so it is widely assumed that Warren Buffett and his Berkshire Hathaway are out looking for deals to make.
A Credit Suisse analyst issued a broad new sector coverage for medical devices and related companies with strong Outperform ratings on Tuesday.
The top analyst upgrades, downgrades and initiations seen on Tuesday included Abbott Laboratories, Albermarle, Boston Scientific, BP, Embraer, Intuit, Marathon Oil and Norfolk Southern.
The top analyst upgrades, downgrades and other research calls from Friday include AMD, CVS Health, Disney, Fiat Chrysler, Kinross Gold, Kohl's and NVIDIA.
Source: Thinkstock24/7 Wall St. has tracked nine key stocks on the move in the after-hours trading session on Tuesday, August 5, 2014. There will have been other movers as well, but these were the...
Here are four top medical device makers that the Leerink team thinks make sense as potential takeover candidates, but also have more than enough merit to stand on their own.
At this time last year, the sentiment on Wall Street for the medtech sector was very poor. The bearish sentiment that prevailed in January of 2013 is gone, but expectations are still tempered. That...
Facebook Inc. (NASDAQ: FB), Groupon Inc. (NASDAQ: GRPN), and Zynga, Inc. (NASDAQ: ZNGA) have all been duds for the market around initial public offerings. These three IPOs have destroyed billions of...
Source: Jon OggThese are the top analyst calls of upgrades, downgrades, and initiations we have seen from Wall St. research calls this Tuesday morning.AK Steel Holding Corp. (NYSE: AKS) cut to Sell...
Globus Medical, Inc. is the latest of the companies filing with the Securities and Exchange Commission to come public via an initial public offering.  No terms were projected yet but the company’s...